Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Entorhinal cortex layer II neurons are among the first neurons to die in Alzheimer's disease. These neurons project to the dentate gyrus via the perforant path and are critical for memory and spatial navigation. Their early vulnerability makes them a key focus for understanding AD pathogenesis.
¶ Location and Structure
The entorhinal cortex is located in the medial temporal lobe, forming the gateway to the hippocampus:
- Layer II: Islands of large neurons (stellate cells)
- Layer III: Smaller pyramidal neurons
- Layer V: Large pyramidal neurons
- Medial entorhinal cortex: Grid cell inputs
- Lateral entorhinal cortex: Object/odor information
- Layer II neurons project to dentate gyrus
- Major input to hippocampal formation
- Conveys cortical information to hippocampus
- Critical for memory encoding
- Medial entorhinal grid cells
- Provide spatial navigation signals
- Support path integration
- Coordinate with place cells
- Initial processing for episodic memory
- Bind cortical sensory information
- Temporal ordering of events
- Support spatial memory
- First neurons affected in AD
- Neurofibrillary tangles appear early (Braak stage I-II)
- Severe neuron loss before clinical symptoms
- Braak staging correlates with cognitive decline
- High metabolic demand
- Long axonal projections
- Tangle pathology spreads through connectivity
- tau pathology originates here
- Neurofibrillary tangles: Hyperphosphorylated tau
- Neuron loss in layer II
- Reduced synaptic density
- Impaired connectivity to hippocampus
- Hyperphosphorylated tau in cell bodies
- Spreads transneuronally
- Related to microtubule dysfunction
- Impairs axonal transport
- Aβ affects layer II neurons
- Synaptic dysfunction
- Disrupted neural circuits
- May accelerate tau pathology
- Oxidative stress
- Neuroinflammation
- Impaired glucose metabolism
- Mitochondrial dysfunction
- Entorhinal atrophy on MRI
- CSF biomarkers (p-tau)
- PET imaging for tau
- Electrophysiological markers
- Anti-tau antibodies
- tau aggregation inhibitors
- Neuroprotective compounds
- Neural circuit restoration
- Early intervention targeting layer II
- tau immunotherapy
- Stem cell-based replacement
- Circuit-specific therapies
The study of Entorhinal Cortex Layer Ii Neurons In Alzheimer'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Van Strien NM, et al. (2009). The anatomy of memory. Nat Rev Neurosci.
- Braak H, Braak E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol.
- Khan UA, et al. (2014). Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease. Nat Neurosci.